Elevation Oncology Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 8, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	675,745	101,132	159,284	217,351	-
Market Cap Growth	107.92%	-36.51%	-26.72%	-	-
Enterprise Value	660,832	105,943	150,428	215,272	-
Last Close Price	82500.00	12730.00	20050.00	25300.00	-
Forward PE	35.48	-	28.14	-	-
PS Ratio	5.33	0.87	1.68	3.18	-
PB Ratio	17.15	3.29	3.38	4.62	-
P/TBV Ratio	29.19	6.64	4.95	6.04	-
P/FCF Ratio	20.94	3.24	-	-	-
P/OCF Ratio	20.09	3.09	-	-	-
EV/Sales Ratio	5.21	0.91	1.58	3.15	-
EV/EBITDA Ratio	34.96	18.00	-	59.48	-
EV/FCF Ratio	20.48	3.39	-	-	-
Debt / Equity Ratio	0.73	0.95	0.63	0.27	-1.34
Debt / EBITDA Ratio	1.53	4.98	-	3.49	4.98
Debt / FCF Ratio	0.90	0.94	-	-	-
Asset Turnover	1.26	1.18	1.08	1.19	-
Inventory Turnover	5.78	6.51	4.80	7.69	-
Quick Ratio	1.32	1.74	1.81	1.50	1.01
Current Ratio	1.64	2.04	2.86	2.09	1.29
Return on Equity (ROE)	-17.74%	-49.77%	-36.32%	-188.12%	-
Return on Assets (ROA)	3.75%	-3.90%	-7.39%	-0.42%	-
Return on Capital (ROIC)	5.29%	-5.63%	-9.59%	-0.71%	-
Return on Capital Employed (ROCE)	10.70%	-	-	-	16.70%
Earnings Yield	-1.07%	-19.22%	-10.77%	-10.56%	-
FCF Yield	4.77%	30.87%	-10.94%	-2.64%	-
Buyback Yield / Dilution	-0.16%	-	-34.73%	-120.82%	-

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.